technologie
Lumecca
April 09,2025
Lumecca, with the detachable Lumecca-I spot size adaptor, delivers precise, targeted IPL procedures. Lumecca is FDA is cleared for the treatment of benign pigmented epidermal lesions, including dyschromia, hyperpigmentation, melasma, ephelides (freckles); The treatment of benign cutaneous vascular lesions, including port wine stains, facial, truncal and leg telangiectasias, rosacea, erythema of rosacea, angiomas and spider angiomas, poikilodenna of Civatte, superficial leg veins and venlous malformations.
